Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Andrew Rasdal Net Worth & Insider Trades

Andrew Rasdal - President, Obalon Therapeutics Inc

As of June 25, 2020

What is Andrew Rasdal's Net Worth?

The current estimated net worth of Obalon Therapeutics Inc's President, Andrew Rasdal, is estimated to be about $3.63M . Andrew Rasdal owns about 77,892 units of Obalon Therapeutics Inc common stock. In the last 4 years at Obalon Therapeutics Inc, Andrew Rasdal has sold an estimated value of $0 worth.

What is Andrew Rasdal's Past Insider Trading?

Andrew Rasdal's largest purchase order was 12,500 units , worth over $50K on August 8, 2019. In total, Andrew Rasdal has made about 9 transactions over 4 years of their time at Obalon Therapeutics Inc. Andrew Rasdal usually trades in January, May, August and November, with the busiest year in 2018.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Andrew Rasdal

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Andrew Rasdal's' Mailing Address?

  • Mailing address is C/o Dexcom, Inc. 5555 Oberlin Drive San Diego CA 92121 CA

What are Obalon Therapeutics Inc's Past Insider Trades?

Obalon Therapeutics Inc's most recent insider trade came on November 14, 2019 by William J Plovanic who bought 65,000 units worth $107.82K . In the last 3 years, insiders at Obalon Therapeutics Inc have sold an estimated value of $10K and bought an estimated value of $7.97M worth of shares. Insider trading is most common in August, with the busiest year in 2018. The most active traders at the company are William J Plovanic,  Amy Vandenberg, Chief Clinical & Reg Officer,  and Mark Brister, Chief Technology Officer .

OBALON THERAPEUTICS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...